Froimson Mark 4
4 · Pacira BioSciences, Inc. · Filed Jun 11, 2020
Insider Transaction Report
Form 4
Froimson Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-09+8,027→ 8,027 totalExercise: $47.65From: 2021-06-09Exp: 2030-06-09→ Common Stock (8,027 underlying) - Award
Common Stock
2020-06-09+1,260→ 5,976 total
Footnotes (1)
- [F1]Represents restricted stock units that vest on June 3, 2021, provided that the reporting person remains in continuous service with the issuer through the vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.